BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+0.42%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.54T
AUM Growth
-$26.8B
(-0.75%)
Cap. Flow
+$3.88B
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
19.15%
Holding
5,729
New
258
Increased
2,183
Reduced
2,656
Closed
133
Top Buys
| 1 |
Moderna
MRNA
|
+$2.88B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$1.91B |
| 4 |
Tesla
TSLA
|
+$1.84B |
| 5 |
Snowflake
SNOW
|
+$1.68B |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$1.12B |
Sector Composition
| 1 | Technology | 23.33% |
| 2 | Healthcare | 13.79% |
| 3 | Financials | 13.24% |
| 4 | Consumer Discretionary | 11.23% |
| 5 | Communication Services | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2476
iShares MSCI China A ETF
CNYA
$219M
| $63.7M | ﹤0.01% |
1,496,919
-326,071
| -18% | -$13.9M |
|
2477
POSCO
PKX
$15.6B
| $63.6M | ﹤0.01% |
922,296
-190,394
| -17% | -$13.1M |
|
|
CAI
2478
DELISTED
CAI International, Inc.
CAI
| $63.3M | ﹤0.01% |
1,131,894
-24,356
| -2% | -$1.36M |
|
2479
Atlanta Braves Holdings Series B
BATRK
$2.61B
| $63.3M | ﹤0.01% |
2,395,131
-2,861
| -0.1% | -$75.6K |
|
2480
DoubleVerify
DV
$2.11B
| $63.1M | ﹤0.01% |
1,848,438
-1,434,433
| -44% | -$49M |
|
2481
Hyliion Holdings
HYLN
$314M
| $63M | ﹤0.01% |
7,497,915
-57,597
| -0.8% | -$484K |
|
2482
Duolingo
DUOL
$12.8B
| $62.5M | ﹤0.01% |
+375,593
| New | +$62.5M |
|
2483
Omeros
OMER
$279M
| $62.4M | ﹤0.01% |
4,525,500
-40,747
| -0.9% | -$562K |
|
|
RUBY
2484
DELISTED
Rubius Therapeutics, Inc
RUBY
| $62.3M | ﹤0.01% |
3,484,480
+48,645
| +1% | +$870K |
|
2485
Replimune Group
REPL
$450M
| $61.9M | ﹤0.01% |
2,088,855
+107,132
| +5% | +$3.18M |
|
2486
Harmony Biosciences
HRMY
$1.85B
| $61.9M | ﹤0.01% |
1,614,173
+309,428
| +24% | +$11.9M |
|
2487
iShares Select Dividend ETF
DVY
$20.5B
| $61.8M | ﹤0.01% |
538,439
-1,514
| -0.3% | -$174K |
|
2488
Utz Brands
UTZ
$1.08B
| $61.7M | ﹤0.01% |
3,603,617
-16,512
| -0.5% | -$283K |
|
2489
OrthoPediatrics
KIDS
$490M
| $61.7M | ﹤0.01% |
941,274
+388
| +0% | +$25.4K |
|
2490
Comstock Resources
CRK
$5.1B
| $61.6M | ﹤0.01% |
5,955,189
+370,466
| +7% | +$3.83M |
|
|
BTRS
2491
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $61.5M | ﹤0.01% |
5,783,226
+750,255
| +15% | +$7.98M |
|
|
KRON
2492
DELISTED
Kronos Bio
KRON
| $61.5M | ﹤0.01% |
2,932,521
+110,276
| +4% | +$2.31M |
|
|
FBMS
2493
DELISTED
The First Bancshares, Inc.
FBMS
| $61.4M | ﹤0.01% |
1,583,533
-16,864
| -1% | -$654K |
|
2494
A10 Networks
ATEN
$1.27B
| $61.3M | ﹤0.01% |
4,544,300
-812,060
| -15% | -$10.9M |
|
2495
Shinhan Financial Group
SHG
$24.3B
| $61.2M | ﹤0.01% |
1,817,680
+58,003
| +3% | +$1.95M |
|
2496
Upland Software
UPLD
$69.9M
| $61.1M | ﹤0.01% |
1,828,309
+27,103
| +2% | +$906K |
|
2497
Transmedics
TMDX
$4.08B
| $61.1M | ﹤0.01% |
1,847,368
+21,724
| +1% | +$719K |
|
|
GTS
2498
DELISTED
Triple-S Management Corporation
GTS
| $61.1M | ﹤0.01% |
1,726,713
-88,093
| -5% | -$3.12M |
|
|
ELAT
2499
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $60.7M | ﹤0.01% |
1,218,139
-16,792
| -1% | -$837K |
|
2500
Rigel Pharmaceuticals
RIGL
$621M
| $60.7M | ﹤0.01% |
1,673,230
-2,061
| -0.1% | -$74.8K |
|